DYNE-101, The placebo is commercially available 0.9% (w/v) saline solution intended for IV
Phase 2 small_molecule active
Quick answer
DYNE-101, The placebo is commercially available 0.9% (w/v) saline solution intended for IV for Myotonic Dystrophy Type 1 is a Phase 2 program (small_molecule) at Dyne Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dyne Therapeutics
- Indication
- Myotonic Dystrophy Type 1
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active